Drug
Fib Grifols
Fib Grifols: highest development phase Phase 3, developed by Grifols. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Grifols
Trials
| Drug | Phase | Indication |
|---|---|---|
| FIB Grifols NCT04636268 | Phase 3 | Congenital Afibrinogenemia |
Latest
No recent events.
Follow Fib Grifols on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.